HIV seroconversion among the homeless and marginally housed in San Francisco: A ten-year study

Journal of Acquired Immune Deficiency Syndromes

Volumn 37, Issue 5, 2004, Pages 1616-1619

  Hahn, Judith A ^a,c   Bangsberg, David R ^a   McFarland, William ^b   Charlebois, Edwin D ^a   Clark, Richard A ^a   Moss, Andrew R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b HIV Seroepidemiology Unit   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

HIV infections epidemiology; Homeless; Incidence; Younger

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; HEALTH SURVEY; HOMELESSNESS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; SEROCONVERSION; UNITED STATES;

AIDS SERODIAGNOSIS; CROSS-SECTIONAL STUDIES; FEMALE; HIV SEROPOSITIVITY; HOMELESS PERSONS; HOUSING; HUMANS; INCIDENCE; MALE; RISK FACTORS; SAN FRANCISCO;

EID: 10644253719     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/00126334-200412150-00015     Document Type: Article

References (21)

1. US Bureau of the Census. Table DP-1. Profile of General Demographic Characteristics: 2000. Geographic Area: San Francisco County, California. 2000. Available at: www.bayareacensus.ca.gov/counties/SanFranciscoCounty.pdf.
2. Smith G. Annual Homeless Count Report: City and County of San Francisco; November 18, 2002. Available at: www.ci.sf.ca.us/site/uploadedfiles/ homeless_count_final_12102.pdf.
3. Annual Unit Usage Report for November 1, 1995. (Residential Hotel Ordinance). San Francisco: Department of Building Inspection, City and County of San Francisco; 1995.
4. US Bureau of the Census. Table DP-3. Profile of Selected Economic Characteristics: 2000. Geographic Area: San Francisco County, California. 2000. Available at: www.bayareacensus.ca.gov/counties/SanFranciscoCounty.pdf.
5. Zolopa AR, Hahn JA, Gorter R, et al. HIV and tuberculosis infection in San Francisco's homeless adults: prevalence and risk factors in a representative sample. [see comments] JAMA. 1994;272:455-461.
6. Robertson M, Clark RA, Charlebois ED, et al. HIV seroprevalence among homeless and marginally housed adults in San Francisco. Am J Public Health. 2004;94:1207-1217.
7. Kushel MB, Perry S, Bangsberg D, et al. Emergency department use among the homeless and marginally housed: results from a community-based study. Am J Public Health. May. 2002;92:778-784.
8. Allen DM, Lehman JS, Green TA, et al. HIV infection among homeless adults and runaway youth, United States, 1989-1992. Field Services Branch. AIDS. 1994;8:1593-1598.
9. HIV/AIDS Annual Epidemiology Report. San Francisco: Department of Public Health; 2002.
10. Kellogg TA, McFarland W, Perlman JL, et al. HIV incidence among repeat HIV testers at a county hospital, San Francisco, California, USA. J Acquir Immune Defic Syndr. 2001;28:59-64.
11. Kral AH, Bluthenthal RN, Lorvick J, et al. Sexual transmission of HIV-1 among injection drug users in San Francisco, USA: risk-factor analysis. Lancet. 2001;357:1397-1401.
12. Moss AR, Vranizan K, Gorter R, et al. HIV seroconversion in intravenous drug users in San Francisco, 1985-1990. AIDS. 1994;8:223-231.
13. McFarland W, Kellogg TA, Dilley J, et al. Estimation of human immunodeficiency virus (HIV) seroincidence among repeat anonymous testers in San Francisco. Am J Epidemiol. 1997;146:662-664.
14. Katz MH, Schwarcz SK, Kellogg TA, et al. Impact of highly active antiretroviral treatment on HIV seroincidence among men who have sex with men: San Francisco. Am J Public Health. 2002;92:388-394.
15. Rosenberg PS. Backcalculation models of age-specific HIV incidence rates. Stat Med. 1994;13:1975-1990.
16. Kral AH, Lorvick J, Gee L, et al. Trends in human immunodeficiency virus seroincidence among street-recruited injection drug users in San Francisco, 1987-1998. Am J Epidemiol. 2003;157:915-922.
17. Strathdee SA, Galai N, Safaiean M, et al. Sex differences in risk factors for HIV seroconversion among injection drug users: a 10-year perspective. Arch Intern Med. 2001;161:1281-1288.
18. Schwarcz SK, Kellogg TA, McFarland W, et al. Characterization of sexually transmitted disease clinic patients with recent human immunodeficiency virus infection. J Infect Dis. 2002;186:1019-1022.
19. Weinstock H, Sweeney S, Satten GA, et al. HIV seroincidence and risk factors among patients repeatedly tested for HIV attending sexually transmitted disease clinics in the United States, 1991 to 1996. STD Clinic HIV Seroincidence Study Group. J Acquir Immune Defic Syndr Hum Retrovirol. 1998;19:506-512.
20. Buchbinder SP, Douglas JM Jr, McKirnan DJ, et al. Feasibility of human immunodeficiency virus vaccine trials in homosexual men in the United States: risk behavior, seroincidence, and willingness to participate. J Infect Dis. 1996;174:954-961.
21. De Rosa CJ, Montgomery SB, Kipke MD, et al. Service utilization among homeless and runaway youth in Los Angeles, California: rates and reasons. J Adolesc Health. 1999;24:449-458.